Stock listing
BCAX Stock Price, News, Filings & Events — Bicara Therapeutics Inc.
Selected listing: BCAX · BOATS · USD · US
This page tracks Bicara Therapeutics Inc.'s BCAX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BCAX:BOATS. BCAX:BOATS is the stock-level entry point for investors researching Bicara Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bicara Therapeutics Inc. is a public company traded under the ticker BCAX in the American market. The company has a market capitalization of approximately $1.82 billion. Bicara focuses on developing innovative therapies, leveraging its expertise to advance treatment options in the healthcare sector.

- Ticker
- BCAX:BOATS
- Asset type
- Stock
- Market cap
- $1.55B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Bicara Therapeutics Inc. BCAX:BOATS stock context
This page tracks Bicara Therapeutics Inc.'s BCAX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BCAX:BOATS. BCAX:BOATS is the stock-level entry point for investors researching Bicara Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bicara Therapeutics Inc. is a public company traded under the ticker BCAX in the American market. The company has a market capitalization of approximately $1.82 billion. Bicara focuses on developing innovative therapies, leveraging its expertise to advance treatment options in the healthcare sector.
Latest news from Bicara Therapeutics Inc.
Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET
August 4, 2026
Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors
July 28, 2026
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 2, 2026
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
May 13, 2026
Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 11, 2026
Bicara Therapeutics Inc. earnings calls
Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Call
August 11, 2026 · Replay with transcript and chapters
Bicara Therapeutics Inc. (BCAX) Q1 2026 Earnings Call
May 11, 2026 · Replay with transcript and chapters
Bicara Therapeutics Inc. (BCAX) Q4 2025 Earnings Call
March 30, 2026 · Replay with transcript and chapters
Research Bicara Therapeutics Inc.
Bicara Therapeutics Inc. investor report
Review AI stock analysis and investor report context for BCAX:BOATS.
Bicara Therapeutics Inc. company profile
View the public company page for Bicara Therapeutics Inc. on 6ix.
Bicara Therapeutics Inc. news
Read company news and market updates connected to Bicara Therapeutics Inc..
Bicara Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Bicara Therapeutics Inc..